By Izzy Wood (Drug Target Review)2023-03-22T12:05:35
US discovery opens the way to drugs that can prevent T cell therapies from losing their potency over time.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-18T14:47:08Z
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2023-03-30T12:35:58
Sponsored by Sartorius
2024-02-02T15:48:26
Sponsored by Bio-Techne
2023-03-28T11:38:32
Sponsored by Bio-Techne
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2025-05-08T10:38:52
Sponsored by Takara Bio USA
Site powered by Webvision Cloud